• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The decision to stop or continue ADHD medications during breastfeeding and pregnancy is a difficult decision for women suffering from the condition. There aren't enough data on how exposure to ADHD for a long time could affect the pregnant fetus.

A study recently published in Molecular Psychiatry shows that children exposed to ADHD medication during utero do not develop neurological developmental disorders such as hearing loss or impaired vision seizures, febrile seizures, or IQ impairment. The authors acknowledge that more high-quality studies are needed.

Risk/Benefit Analysis

Women who are pregnant and taking ADHD medications need to balance the benefits of taking them against the potential risks to the foetus. The doctors don't have the information to provide clear recommendations but they can provide information on the risks and benefits to assist pregnant women to make informed choices.

A study published in Molecular Psychiatry concluded that women who took ADHD medication in early pregnancy were not at higher risk of fetal malformations or structural birth defects. The researchers used a large, population-based case-control study to determine the prevalence of major structural birth defects in infants born to mothers who took stimulants during the early stages of pregnancy, as well as those who had not. Pediatric cardiologists, clinical geneticists and other experts looked over the cases to make sure that the classification was accurate and to eliminate any bias.

The study of the researchers had some limitations. Researchers were unable, in the first place to distinguish the effects caused by the medication from the disorder. This limitation makes it difficult for researchers to establish whether the small differences observed between the groups that were exposed to medication use or if they were caused by the presence of comorbidities. Researchers also did not look at long-term outcomes for the offspring.

The study did show that infants whose mothers had taken ADHD medication during pregnancy were at slightly greater risk of being admitted to the neonatal intensive care unit (NICU) than infants who were born without any medication or had cut back on their medications prior to or during pregnancy. This increase was due to central nervous system-related disorders and the increased risk of admission did not appear to be affected by the type of stimulant medications were used during pregnancy.

Women who were taking stimulant ADHD medications during pregnancy also had a higher chance of having to have a caesarean section or a baby that scored low on the Apgar scale (less than 7). These increases appeared to be unrelated to the type of medication used during pregnancy.

Researchers suggest that the minor risks posed by the use of adhd medication pregnancy medication during pregnancies in the early stages can be offset by more beneficial outcomes for both mother and baby of continuing treatment for the woman’s disorder. Doctors should discuss with their patients about this and as much as possible, assist them develop coping strategies that may reduce the effects of her disorder on her daily life and relationships.

Interactions with Medication

More and more doctors are confronted with the dilemma of whether to continue treatment or stop as more women are diagnosed with ADHD. The majority of these decisions are made in the absence of clear and authoritative evidence either way, so physicians must weigh what they know about their experiences, the experiences of other doctors, and what the research suggests about the subject, along with their own best non stimulant adhd medication for adults judgment for each patient.

The issue of risk to infants is particularly tricky. A lot of studies on this subject are based on observational data instead of controlled research and their findings are often contradictory. Most studies limit their analysis to live-births, which could underestimate the severity of teratogenic effects leading to abortions or terminations of pregnancy. The study that is discussed in this journal club addresses these issues by analyzing data on live and deceased births.

Conclusion: While some studies have revealed an association between ADHD medications and certain birth defects however, other studies haven't established a link. Most studies show that there is a neutral, or slightly negative, impact. In the end an accurate risk-benefit analysis is required in every instance.

For a lot of women with strongest adhd medication for adults, the decision to discontinue medication is difficult, if not impossible. In a recent piece published in the Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping adhd medication Weekends adults ADHD medications during pregnancy can increase depression and feelings of being isolated. A loss of medication may also impact the ability to safely drive and perform work-related tasks, which are essential aspects of everyday life for those suffering from ADHD.

She suggests that women who aren't sure whether to take the medication or stop due to pregnancy, educate their family members, coworkers and friends about the condition, its effects on daily functioning, and the advantages of staying on the current treatment regimen. In addition, educating them can help the woman feel supported when she is struggling with her decision. It is important to remember that certain drugs can be absorbed through the placenta so if a woman decides to stop taking her ADHD medication during pregnancy and breastfeeding, she must be aware that traces of the medication could be transferred to the child.

Risk of Birth Defects

As the use of ADHD medications to treat symptoms of attention deficit hyperactivity disorder (ADHD) increases there are concerns about what impact the drugs could have on the fetuses. A study that was published in the journal Molecular Psychiatry adds to the body of knowledge about this subject. Researchers used two massive datasets to analyze more than 4.3 million pregnancy and determine if stimulant medication use increased birth defects. While the overall risk remains low, the scientists discovered that the first-trimester exposure to ADHD medications was associated with a slightly higher rate of certain heart defects, like ventriculo-septal defects (VSD).

The researchers of the study didn't discover any connection between early use of medication and other congenital anomalies like facial deformities, or club feet. The findings are in line with previous studies revealing an increase, but not significant, in the risk of heart malformations among women who started taking ADHD medications prior to the time of pregnancy. The risk was higher in the latter half of pregnancy, when a lot of women decide to stop taking their ADHD medications.

Women who used ADHD medications during the first trimester of their pregnancies were also more likely to experience a caesarean section, a low Apgar score following delivery, and a baby who needed help breathing at birth. The authors of the study were not able to eliminate selection bias because they restricted the study to women who did not have any other medical conditions that could have contributed to the findings.

Researchers hope that their research will provide doctors with information when they meet pregnant women. They suggest that although the discussion of the risks and benefits is crucial, the decision to stop or maintain medication should be based on the woman's requirements and the severity of her ADHD symptoms.

The authors also caution that even though stopping the medication is an option, it is not an option to consider due to the high incidence of depression and other mental health problems among women who are pregnant or who are recently post-partum. Research has also shown that women who stop taking their medication will have a difficult adjustment to life without them after the baby is born.

Nursing

It can be a challenge to become a mom. Women who suffer from ADHD can face severe challenges when they must deal with their symptoms, attend doctor appointments and prepare for the birth of a child and adjust to a new routine. Many women opt to continue taking their ADHD medication during pregnancy.

The risk for breastfeeding infant is not too high since the majority of stimulant medications passes through breast milk at low levels. The amount of exposure to medications will vary based on the dosage the medication is administered, its frequency and the time of the day. In addition, various medications are introduced into the baby's system through the gastrointestinal tract or through breast milk. The impact of these medications on a newborn's health is not fully understood.

Due to the absence of evidence, some doctors may be inclined to discontinue stimulant medications during the course of pregnancy. It's a difficult choice for the mother, who must weigh the advantages of her medication against the risks to the embryo. Until more information becomes available, GPs can inquire about pregnant patients if they have any background of ADHD or if they plan to take medication in the perinatal period.

A increasing number of studies have shown that most women can safely continue taking their ADHD medication during pregnancy and breastfeeding. In response, a growing number of patients are opting to do so. They have found through consultation with their doctor that the benefits of retaining their current medication far outweigh any possible risks.

It is crucial for women suffering from ADHD who are thinking different types of adhd medication breastfeeding to seek a specialist psychiatrist's advice prior to becoming pregnant. They should review their medications with their prescriber and discuss the advantages and disadvantages of continued treatment, including non-pharmacological management strategies. Psychoeducation is also required to help women with ADHD understand their symptoms and underlying disorder Learn about the available treatments and to reinforce existing coping strategies. This should be a multidisciplinary approach including obstetricians, GPs and psychiatrists. Pregnancy counseling should consist of a discussion of a treatment plan for the mother as well as the child, and monitoring for signs of deterioration and, if needed adjustments to the medication regime.